Wille Sandrina SRL
Wille Sandrina reported total assets of €4.26m at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Mar 2026).
The score of Wille Sandrina shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +91 % Total assets +8 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Wille Sandrina's annual accounts
Filed annual accounts
- Year ended 30 Sep 2025filed on 31 Mar 2026
- Year ended 30 Sep 2024filed on 09 Apr 2025
- Year ended 30 Sep 2023filed on 04 Apr 2024
- Year ended 30 Sep 2022filed on 28 Apr 2023
- Year ended 30 Sep 2021filed on 29 Mar 2022
Wille Sandrina's financial analysis
- Solvency40.0%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Wille Sandrina
Wille Sandrina's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0841.449.165
- VAT number
- BE0841449165
- Peppol
- Registered · 0208:0841449165 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 30 Nov 2011
- Registered office
- 1853 Grimbergen
- Latest accounts
- 2025 · filed on 31 Mar 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Wille Sandrina (SRL) has been based in Grimbergen since 2011, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 284,469 € and equity of €1.70m; its revenue is not published. Its solvency stands at 40.0%, below the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Wille Sandrina
Companies in the same business, of comparable size and area, outside its group.
- PG Pharmaceuticals Business and other management consultancy activities Opwijk · balance sheet €1.86m
- Pharmacie Brasseur L. Business and other management consultancy activities Wavre · balance sheet €1.05m
- APO2370 Retail sale of pharmaceutical products Arendonk · balance sheet €3.86m
- ACP-Pharma Retail sale of pharmaceutical products Affligem · balance sheet 48,017 €
- Pharmanext Retail sale of pharmaceutical products Ixelles · balance sheet €2.33m
- Yascare Retail sale of pharmaceutical products Uccle · balance sheet 34,424 €
- Conrad Pharma Retail sale of pharmaceutical products Oudenaarde · balance sheet €5.01m
- Tervest Retail sale of pharmaceutical products Tervuren · balance sheet €4.38m
Frequently asked questions about Wille Sandrina
What is the revenue of Wille Sandrina?
Wille Sandrina files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Wille Sandrina?
In Belgium, the VAT number is the company number prefixed with BE: BE0841449165 for Wille Sandrina, if the company is VAT-registered. Its company number (CBE) is 0841.449.165.
Where is the registered office of Wille Sandrina?
According to the CBE register, the registered office of Wille Sandrina is in 1853 Grimbergen.
What is the equity of Wille Sandrina?
At the close of the 2025 financial year, the equity of Wille Sandrina amounts to 1,704,414 €, a solvency of 40.0% of total assets.
Who manages Wille Sandrina?
The register lists 1 active mandates at Wille Sandrina. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Wille Sandrina
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →